Science Wiki

Cholesterol (C₂₇H₄₆O, molar mass 386.65 g·mol⁻¹) is an amphiphilic, 27-carbon tetracyclic sterol lipid that serves as an essential structural modulator of vertebrate cell membranes and the universal metabolic precursor for steroid hormones, bile acids, and vitamin D₃. Comprising roughly 30% to 50% of the total lipid molecules in the eukaryotic plasma lipid bilayer, cholesterol intercalates between phospholipid acyl chains via the hydrophobic effect to bidirectionally buffer membrane fluidity across physiological temperature shifts while reducing passive permeability to small cations. Beyond membrane biophysics, tightly regulated cholesterol homeostasis—governed by de novo synthesis through the hepatic mevalonate pathway and systemic transport inside low-density and high-density lipoproteins (LDL and HDL)—is a central determinant of human cardiovascular physiology and neurobiology, with the brain alone housing ~25% of total body cholesterol within insulating myelin sheaths.

Unlike glycerophospholipids and triacylglycerols, which contain long, flexible esterified fatty acyl chains, cholesterol is built around a rigid, planar four-ring hydrocarbon nucleus known as the cyclopentanoperhydrophenanthrene (sterane) ring system (designated rings A, B, C, and D).

Amphiphilic Sterol Orientation in the Membrane

Cholesterol's molecular architecture consists of three distinct functional domains that dictate its alignment inside a phospholipid bilayer:

1. The C3β-Hydroxyl Headgroup (–OH): A single polar hydroxyl group attached at carbon-3 of the A-ring. Unlike the bulky phosphocholine headgroups of phosphatidylcholine, this compact –OH moiety sits flush with the ester carbonyl oxygens of adjacent phospholipids, donating a stabilizing hydrogen bond while exposing minimal surface area to bulk water.
2. The Rigid Tetracyclic Sterane Core (Rings A–D): A trans-fused, flat, and conformationally inflexible four-ring steroid nucleus (~0.75 nm long) with two axial methyl groups (C18 and C19) protruding from its β-face.
3. The Isooctyl Hydrocarbon Tail (C20–C27): A flexible, branched eight-carbon aliphatic chain attached at C17 of the D-ring that extends deep into the hydrophobic midplane of the bilayer leaflet.

Bidirectional Fluidity Buffering and the Liquid-Ordered (L_o) Phase

When intercalated at 20 to 50 mol% into a phospholipid membrane, cholesterol abolishes the sharp cooperative endothermic melting transition (the main phase transition temperature, T_m) between the rigid solid-like gel phase (L_β) and the fluid liquid-crystalline phase (L_α), creating an intermediate biophysical state known as the liquid-ordered (L_o) phase:

Lipid Rafts and Sphingolipid Microdomains

Within the plasma membrane, cholesterol exhibits a preferential thermodynamic affinity for sphingolipids (such as sphingomyelin and glycosphingolipids), whose long, saturated acyl chains and hydrogen-bond-donating amide linkages pack snugly against the smooth α-face of the sterane ring. This selective association drives lateral phase separation into nanoscopic (10–200 nm), transient lipid rafts—liquid-ordered (L_o) microdomains that concentrate GPI-anchored proteins, Src-family tyrosine kinases, and transmembrane signaling receptors to coordinate signal transduction and endocytosis.

Every single carbon atom of cholesterol's 27-carbon skeleton derives from two-carbon acetyl-CoA units via a 30-step enzymatic cascade spanning the cytosol and endoplasmic reticulum (ER) membrane, elucidated in classic radiolabeling studies by Konrad Bloch and Feodor Lynen (1964 Nobel Prize).

The Four Stages of the Mevalonate Pathway

1. Condensation of 3 Acetyl-CoA to Mevalonate (C₆): Two molecules of acetyl-CoA condense via thiolase to form acetoacetyl-CoA, which condenses with a third acetyl-CoA via HMG-CoA synthase to yield 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). Next, the integral ER membrane enzyme HMG-CoA reductase catalyzes the irreversible, rate-limiting reduction of HMG-CoA using two molecules of NADPH to produce mevalonate (6 carbons).
2. Conversion of Mevalonate to Activated Isoprenes (C₅): Three sequential ATP-dependent phosphorylations followed by an ATP-driven decarboxylation convert mevalonate into the five-carbon isoprene isomers isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).
3. Head-to-Tail Condensation to Squalene (C₃₀): IPP and DMAPP condense ( C₅ + C₅ → geranyl pyrophosphate, C₁₀; + C₅ → farnesyl pyrophosphate (FPP), C₁₅). Two molecules of FPP then join head-to-head via squalene synthase (consuming one NADPH) to form the linear 30-carbon triterpene squalene.
4. Oxidosqualene Cyclization to Lanosterol and Cholesterol (C₂₇): Squalene monooxygenase adds an epoxide oxygen (requiring O₂ and NADPH) to form 2,3-oxidosqualene. Oxidosqualene cyclase then catalyzes a concerted cationic polycyclization cascade with methyl and hydride shifts to fold the linear chain into the tetracyclic sterol lanosterol (C₃₀), which undergoes 19 subsequent ER-localized demethylations and double-bond reductions (the Bloch and Kandutsch-Russell pathways) to yield cholesterol (C₂₇).

Overall, synthesizing a single molecule of cholesterol from 18 acetyl-CoA molecules requires an enormous bioenergetic investment of 18 acetyl-CoA, 36 ATP, and ~16–26 NADPH, explaining why cells enforce stringent feedback regulation over the pathway.

SREBP-SCAP Transcriptional Feedback and Statin Pharmacology

Cellular cholesterol levels are sensed directly in the ER membrane by SCAP (SREBP cleavage-activating protein), which binds the transcription factor SREBP-2 (sterol regulatory element-binding protein 2). When ER cholesterol falls below ~5 mol% of ER lipids, SCAP escorts SREBP-2 to the Golgi apparatus, where Site-1 and Site-2 proteases cleave and release its soluble N-terminal transcription factor domain into the nucleus to upregulate transcription of the HMG-CoA reductase and LDL receptor genes. Conversely, when cholesterol is abundant, cholesterol binds SCAP and oxysterols bind Insig, anchoring the SCAP-SREBP complex inside the ER and triggering ubiquitination and proteasomal degradation of HMG-CoA reductase.

Statin drugs (such as atorvastatin, rosuvastatin, and lovastatin) possess a mevalonate-like pharmacophore that acts as a competitive inhibitor of HMG-CoA reductase (K_i ≈ 0.1–1 nM versus K_m ≈ 4 μM for HMG-CoA). By inhibiting hepatic cholesterol synthesis, statins trigger SREBP-2 activation in hepatocytes, dramatically upregulating surface LDL receptors that clear atherogenic LDL particles from the bloodstream.

Because cholesterol is virtually insoluble in aqueous blood plasma (critical micelle concentration ~25–40 nM), vertebrates solubilize and transport cholesterol inside spherical macromolecular nanoparticles called lipoproteins—comprising an amphiphilic outer monolayer of phospholipids, unesterified cholesterol, and apolipoproteins surrounding an anhydrous core of triglycerides and cholesteryl esters (cholesterol esterified at C3–OH with a long-chain fatty acid by ACAT or LCAT).

• Low-Density Lipoproteins (LDL, ~22 nm, ApoB-100): Deliver cholesterol from the liver to peripheral tissues via receptor-mediated endocytosis discovered by Michael Brown and Joseph Goldstein. Excess plasma LDL penetrates Damaged arterial endothelium, becomes oxidized by reactive oxygen species, and is engulfed by macrophages to form lipid-laden foam cells that drive atherosclerotic plaque formation.
• High-Density Lipoproteins (HDL, ~8–12 nm, ApoA-I): Execute reverse cholesterol transport, extracting excess unesterified cholesterol from peripheral macrophages via ABCA1/ABCG1 transporters, esterifying it via lecithin-cholesterol acyltransferase (LCAT), and returning it to the liver for excretion.

Because human cells lack enzymes capable of catabolizing the sterane ring system back into CO₂ and water, excess cholesterol is eliminated exclusively through the liver—either secreted directly into bile or converted by cholesterol 7α-hydroxylase (CYP7A1) into amphiphilic bile acids (cholic acid and chenodeoxycholic acid) that emulsify dietary fats in the small intestine. In endocrine tissues (adrenal cortex, gonads, placenta), mitochondrial cytochrome P450scc (CYP11A1) cleaves the C20–C27 side chain of cholesterol to yield pregnenolone (C₂₁), the common precursor of all five classes of steroid hormones: glucocorticoids (cortisol), mineralocorticoids (aldosterone), androgens (testosterone), estrogens (estradiol), and progestogens (progesterone).

Is cholesterol present in bacteria or plant cell membranes?

Prokaryotic bacteria (with rare exceptions such as Mycoplasma that scavenge host sterols) do not synthesize cholesterol; instead, many bacteria use pentacyclic triterpenoids called hopanoids (such as diploptene) to stiffen their membranes. Similarly, land plants synthesize virtually negligible cholesterol and instead regulate plasma membrane fluidity using C₂₈ and C₂₉ phytosterols (sitosterol, stigmasterol, and campesterol), while fungi utilize ergosterol (the target of amphotericin B and azole antifungals).

Why is LDL called "bad cholesterol" and HDL called "good cholesterol"?

The cholesterol molecule itself is chemically identical in both particles; the distinction lies in the lipoprotein transport vector. LDL particles carry ~65%–70% of plasma cholesterol outward to peripheral tissues; when circulating LDL exceeds cellular receptor capacity (as in familial hypercholesterolemia caused by LDLR or PCSK9 mutations), particles accumulate in the arterial intima and initiate atherosclerosis. Conversely, HDL particles scavenge excess cholesterol from arterial walls and return it to the liver for biliary disposal.

How does ultraviolet sunlight convert cholesterol precursors into Vitamin D?

During the final steps of cholesterol synthesis in epidermal keratinocytes of the skin, the intermediate 7-dehydrocholesterol (which contains conjugated double bonds at C5=C6 and C7=C8 in the B-ring) absorbs solar ultraviolet B (UVB) photons (wavelengths 290–315 nm). This photolytic electrocyclic ring-opening cleaves the C9–C10 bond of the B-ring to form previtamin D₃, which thermally isomerizes into cholecalciferol (vitamin D₃) and is subsequently hydroxylated in the liver and kidneys into the active calcium-regulating hormone calcitriol (1,25-dihydroxyvitamin D₃).